Related Experiment Video
Updated: Jun 5, 2026
06:26
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Rational methods for the selection of diverse screening compounds.
David J Huggins1, Ashok R Venkitaraman, David R Spring
1TCM Group, Cavendish Laboratory, University of Cambridge, United Kingdom.
ACS Chemical Biology
|January 26, 2011
Summary
Assembling diverse compound collections is crucial for successful high-throughput screening (HTS) in academic labs. Rational selection methods maximize hit rates and minimize false positives in drug discovery.
Area of Science:
- Drug Discovery
- Chemical Biology
- Assay Development
Background:
- High-throughput screening (HTS) assays, once limited to large pharmaceutical companies, are now prevalent in academic and government research.
- This expansion enables non-commercially viable projects like chemical probe discovery and screening against challenging targets.
Purpose of the Study:
- To discuss factors and methods for assembling structurally diverse compound collections for HTS.
- To highlight the importance of optimized compound collections for maximizing hit rates and minimizing false positives.
Main Methods:
- Review of factors influencing compound collection design for HTS.
- Discussion of rational methods for selecting diverse chemical libraries.
- Consideration of protein targets and downstream assays in compound selection.
Main Results:
- An optimized compound collection is essential for effective HTS.
- Failure to consider targets and assays can limit chemical diversity and novelty.
- Rational selection strategies are key to successful compound library utilization.
Conclusions:
- The strategic assembly of diverse compound collections is vital for the success of HTS.
- Effective compound selection enhances the discovery of novel chemical matter.
- Academic and government labs can leverage HTS for critical research endeavors.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...